Immunofluorescence analysis of U-2 OS/centrin-GFP cells treated with MG132 (1 µM), MG262 (0.001 µM), or epoxomicin (0.01 µM) for 96 h. Cells treated with 0.1% DMSO for 96 h were used as controls. Protease-catalyzed cleavage of the red-fluorescent dye-labeled BODIPY TR-X-casein relieves the inherent quenching of the dye and results in brightly fluorescent BODIPY TR-X dye-labeled peptides. Scale bar indicates 10 µm.
Supplementary Figure 2. Immunoblot and immunofluorescence controls of protein knock-down.
(A) Immunoblot analysis of U-2 OS-centrin/GFP cells treated for 72 h with either control or siRNA duplexes targeting FOP, CAP350, Cep97, CP110, C-Nap1, and Cep170. Immunoblot for actin demonstrates protein loading.
(B) Immunofluorescence analysis of U-2 OS-centrin/GFP cells treated for 72 h with either control (siControl) or siRNA duplexes specific for ninein (siNinein), CPAP (siCPAP), or hSAS-6 (sihSAS-6). Table 1 . Genes and siRNA target sequences used for siRNA library screen. The first and second target sequence for each gene corresponds to the siRNAs used for the primary and secondary screens, respectively.
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